@prefix dcterms: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix npx: .
@prefix xsd: .
@prefix orcid: .
@prefix rdfs: .
@prefix fip: .
@prefix prov: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
dcterms:isPartOf ;
a fip:FAIR-Implementation-Community;
rdfs:comment "In the Cancer Therapeutics and Drug Safety research group at the LACDR, headed by prof. dr. Bob van de Water, cell signaling programs that underlie adverse drug reactions as well as cancer development and progression are unraveled.";
rdfs:label "LACDR DDS CTDS | Cancer Therapeutics and Drug Safety, Division of Drug Discovery & Safety, LACDR, Leiden University";
rdfs:seeAlso ;
fip:has-research-domain .
}
sub:provenance {
sub:assertion dcterms:creator orcid:0000-0001-7525-9218 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCoKFb7LKlXyBB7BUvjFF9bDJNk0WxH3Xerr4H3v/VCiRVshEDl3BZVekbMMmdRe+TOPyc8AOLd9IAL2VfVVD/T0rmCHk7Pw7DQjI96mwyeXhE7f4g0WG5UT5Pxxm0Rzy7IrYnEaaVDs7dkZUt952M6qWlHfTwCQDcXJhZfLiXoMwIDAQAB";
npx:hasSignature "ptJ4lbRRypPGs70cEIdem4eL0bmjH8DFVMWp97RlB3IWRJpK5onjDqP4m3LgMW7fhiv2GWLQ/2wo6iIIBD9GXDwam6QVUgjxtZ3iJySROhtl77+ICx+VPbLDVgYKXZjUNe+hDWUgzuYSY7B3M52h6qakqdnes7kZS/kla+tE7BQ=";
npx:hasSignatureTarget this: .
this: dcterms:created "2023-07-13T21:28:24Z"^^xsd:dateTime;
dcterms:creator ;
dcterms:license ;
npx:introduces ;
npx:supersedes ;
prov:wasDerivedFrom .
}